These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33310833)

  • 1. Malignant eosinophilic ascites due to metastatic urothelial carcinoma with peritoneal carcinomatosis.
    Carranza M; Chahin M; Siddiqi A; House J
    BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33310833
    [No Abstract]   [Full Text] [Related]  

  • 2. A rare pure lymphoepithelioma-like carcinoma of the renal pelvis mimicking upper tract urothelial carcinoma: A potential diagnostic pitfall.
    Chen YC; Chen HW; Chueh KS; Wei YC
    Kaohsiung J Med Sci; 2018 Nov; 34(11):657-658. PubMed ID: 30392573
    [No Abstract]   [Full Text] [Related]  

  • 3. Surgical palliation of incurable urologic cancer.
    Alagiri M; Greenberg RE
    Curr Probl Cancer; 1995; 19(6):360-71. PubMed ID: 8903673
    [No Abstract]   [Full Text] [Related]  

  • 4. Mesenteric fibromatosis presenting with ascites in childhood.
    Mecrow IK; Miller V; Lendon M; Doig CM
    J Pediatr Gastroenterol Nutr; 1990 Jul; 11(1):118-22. PubMed ID: 2388122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of apoptosis in urothelial carcinoma. 1. Role of apoptosis in the development of urothelial carcinoma].
    Savin M; Petronić V
    Srp Arh Celok Lek; 1999; 127(7-8):258-65. PubMed ID: 10624400
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic significance of urothelial carcinoma with divergent differentiation in upper urinary tract after radical nephroureterectomy without metastatic diseases: A retrospective cohort study.
    Qin C; Liang EL; Du ZY; Qiu XY; Tang G; Chen FR; Zhang B; Tian DW; Hu HL; Wu CL
    Medicine (Baltimore); 2017 May; 96(21):e6945. PubMed ID: 28538387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ascites, mass volume, and peritoneal carcinomatosis on serum CA125 levels in patients with ovarian carcinoma.
    Saygili U; Guclu S; Uslu T; Erten O; Dogan E
    Int J Gynecol Cancer; 2002; 12(5):438-42. PubMed ID: 12366659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in upper tract urothelial carcinomas.
    Singla N; Ghandour RA; Margulis V
    Curr Opin Urol; 2019 May; 29(3):256-260. PubMed ID: 30762671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative proteomic analysis of human malignant ascitic fluids for the development of gastric cancer biomarkers.
    Jin J; Son M; Kim H; Kim H; Kong SH; Kim HK; Kim Y; Han D
    Clin Biochem; 2018 Jun; 56():55-61. PubMed ID: 29654727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of CT-defined minimal ascites in patients with gastric cancer.
    Chang DK; Kim JW; Kim BK; Lee KL; Song CS; Han JK; Song IS
    World J Gastroenterol; 2005 Nov; 11(42):6587-92. PubMed ID: 16425349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urothelial carcinoma presenting with distant metastasis to the rectum.
    Esfandiari A; Speakman C
    BMJ Case Rep; 2016 Feb; 2016():. PubMed ID: 26838297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differential diagnosis and pathophysiologic principles of ascites].
    Paumgartner G; Gerbes AL
    Chirurg; 1993 Jan; 64(1):1-6. PubMed ID: 8382146
    [No Abstract]   [Full Text] [Related]  

  • 13. Promoter hypermethylation: a new therapeutic target emerges in urothelial cancer.
    Cote RJ; Laird PW; Datar RH
    J Clin Oncol; 2005 May; 23(13):2879-81. PubMed ID: 15753457
    [No Abstract]   [Full Text] [Related]  

  • 14. The modern management of upper urinary tract urothelial cancer: tumour diagnosis, grading and staging.
    Painter DJ; Timoney AG; Denton K; Alken P; Keeley FX
    BJU Int; 2007 May; 99(5):973-7. PubMed ID: 17437428
    [No Abstract]   [Full Text] [Related]  

  • 15. Surgical treatment of disseminated peritoneal metastases from urological cancer: results from a prospective study.
    Otto T; Suhr J; Krege S; Goebell PJ; Wishahi M; Bier UW; Kimmig R; Rübben H
    BJU Int; 2002 Dec; 90(9):823-7. PubMed ID: 12460339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of squamous and glandular differentiation on oncologic outcomes in upper and lower tract urothelial carcinoma.
    Lee YJ; Moon KC; Jeong CW; Kwak C; Kim HH; Ku JH
    PLoS One; 2014; 9(9):e107027. PubMed ID: 25191845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of malignant ascites.
    Chung M; Kozuch P
    Curr Treat Options Oncol; 2008 Jun; 9(2-3):215-33. PubMed ID: 18777213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Value of Carcinoembryonic Antigen in Ascites for Colorectal Cancer with Peritoneal Carcinomatosis.
    Song SE; Choi P; Kim JH; Jung K; Kim SE; Moon W; Park MI; Park SJ
    Korean J Gastroenterol; 2018 Jun; 71(6):332-337. PubMed ID: 29943560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvements in endoscopic urothelial tumor visualization.
    Kamphuis G; de Reijke T; de la Rosette J
    J Endourol; 2013 Nov; 27(11):1314-5. PubMed ID: 24138053
    [No Abstract]   [Full Text] [Related]  

  • 20. Fine-needle aspiration diagnosis of metastatic urothelial carcinoma: a review.
    Cantley RL; Kapur U; Truong L; Cimbaluk D; Barkan GA; Wojcik E; Gattuso P
    Diagn Cytopathol; 2012 Feb; 40(2):173-8. PubMed ID: 22246936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.